DK1791423T3 - Sammensætninger og fremgangsmåder til behandling af hyperproliferative dermatologiske tilstande - Google Patents

Sammensætninger og fremgangsmåder til behandling af hyperproliferative dermatologiske tilstande

Info

Publication number
DK1791423T3
DK1791423T3 DK04795060.5T DK04795060T DK1791423T3 DK 1791423 T3 DK1791423 T3 DK 1791423T3 DK 04795060 T DK04795060 T DK 04795060T DK 1791423 T3 DK1791423 T3 DK 1791423T3
Authority
DK
Denmark
Prior art keywords
compositions
methods
dermatological conditions
treating hyperproliferative
hyperproliferative dermatological
Prior art date
Application number
DK04795060.5T
Other languages
Danish (da)
English (en)
Inventor
Muhammed Majeed
Subbalakshmi Prakash
Original Assignee
Sami Labs Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/710,778 external-priority patent/US7582314B2/en
Application filed by Sami Labs Ltd filed Critical Sami Labs Ltd
Application granted granted Critical
Publication of DK1791423T3 publication Critical patent/DK1791423T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/324—Boswellia, e.g. frankincense
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
DK04795060.5T 2004-08-02 2004-10-14 Sammensætninger og fremgangsmåder til behandling af hyperproliferative dermatologiske tilstande DK1791423T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/710,778 US7582314B2 (en) 2003-12-03 2004-08-02 Compositions and methods for the management of hyperproliferative dermatological conditions
PCT/US2004/033846 WO2006022762A1 (en) 2004-08-02 2004-10-14 Compositions and methods for the management of hyperproliferative dermatological conditions

Publications (1)

Publication Number Publication Date
DK1791423T3 true DK1791423T3 (da) 2013-08-05

Family

ID=35967805

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04795060.5T DK1791423T3 (da) 2004-08-02 2004-10-14 Sammensætninger og fremgangsmåder til behandling af hyperproliferative dermatologiske tilstande

Country Status (12)

Country Link
EP (1) EP1791423B1 (https=)
JP (1) JP4820819B2 (https=)
CN (1) CN101132693B (https=)
AU (1) AU2004322710B2 (https=)
DK (1) DK1791423T3 (https=)
ES (1) ES2422893T3 (https=)
NZ (1) NZ552027A (https=)
PL (1) PL1791423T3 (https=)
PT (1) PT1791423E (https=)
RU (1) RU2366412C2 (https=)
WO (1) WO2006022762A1 (https=)
ZA (1) ZA200700694B (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101682512B1 (ko) * 2008-09-15 2016-12-05 라일라 뉴트라슈티칼스 보스웰리아 세라타 추출물을 포함하는 상승적인 항-염증 조성물
ITVR20080125A1 (it) * 2008-11-13 2010-05-14 Phytonature Sas Di Masini Dr Antoni O E C Nuova forma di preparazione ed utilizzo della boswellia serrata
RU2578025C2 (ru) * 2010-02-15 2016-03-20 Лайла Ньютрасьютикалз Новый низкополярный экстракт камеде-смолы boswellia и его синергетические композиции
US20110218172A1 (en) * 2010-03-02 2011-09-08 Muhammed Majeed Composition for down-regulating pro-inflammatory markers
CN102670690A (zh) * 2011-03-14 2012-09-19 苏州博创园生物医药科技有限公司 一种抗牛皮癣纯天然药物乳膏及其制备方法
CN102670565A (zh) * 2011-03-14 2012-09-19 苏州博创园生物医药科技有限公司 一种含天然药物的透皮吸收贴片
CN103193853A (zh) * 2012-01-06 2013-07-10 苏州博创园生物医药科技有限公司 用于治疗银屑病的化合物、组合物及其制备方法
US9498423B2 (en) * 2012-05-07 2016-11-22 Sami Labs Limited Synergistic selenopeptide formulations for the protection of dermal papilla cells
JP2019513775A (ja) * 2016-04-19 2019-05-30 アズーラ オフサルミックス エルティーディー． 角化症の処置のための組成物
US9975917B1 (en) 2017-09-20 2018-05-22 King Saud University Pentacyclic triterpenoidal derivatives
EP4087655A4 (en) 2020-01-10 2024-02-21 Azura Ophthalmics Ltd INSTRUCTIONS FOR COMPOSITION AND SENSITIVITY
EP4295842A1 (en) 2022-06-24 2023-12-27 Faaborg Pharma - IP ApS A skin care composition

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3670084A (en) * 1969-06-20 1972-06-13 Leopoldo F Montes Method of treating psoriasis with cycloheximide
DE4201903B4 (de) * 1992-01-24 2004-04-15 Hermann P.T. Prof. Dr.Med. Ammon Pharmazeutische Verwendung von Boswelliasäuren
DE4445728A1 (de) * 1994-12-21 1996-06-27 Simmet Th Prof Dr Verwendung von Boswelliasäure zur Behandlung von Hirntumoren
US5536506A (en) * 1995-02-24 1996-07-16 Sabinsa Corporation Use of piperine to increase the bioavailability of nutritional compounds
RU2152218C1 (ru) * 1998-04-21 2000-07-10 Дальневосточный государственный медицинский университет Способ лечения псориаза
CN1064264C (zh) * 1998-04-28 2001-04-11 山东省滨州卫生学校 富硒灵芝在制备治疗银屑病的药物中的应用
US6399105B1 (en) * 1999-01-20 2002-06-04 Peter Donald Collin Sea cucumber carotenoid lipid fraction products and methods of use
WO2000066111A1 (en) * 1999-04-30 2000-11-09 Sabinsa Corporation Compositions of boswellic acids derived from boswellia serrata gum resin, for treating lymphoproliferative and autoimmune conditions
CA2451267A1 (en) * 2002-12-13 2004-06-13 Warner-Lambert Company Llc Pharmaceutical uses for alpha2delta ligands
GB0230203D0 (en) * 2002-12-27 2003-02-05 Domantis Ltd Fc fusion
BR0317885A (pt) * 2002-12-30 2005-12-06 Celgene Corp Composto, isÈmeros s e r enantiomericamente puros do mesmo, composição farmacêutica e métodos de inibir pde4 e mmp, de modular a produção de tnf-alfa, de tratar ou prevenir mds, de tratar doença mieloproliferativa, angiogênese indesejada, câncer, uma doença, inflamação dos pulmões, depressão, distúrbio pulmonar obstrutivo crÈnico, doença inflamatória do intestino, dermatite atópica, psorìase, doença de crohn, artrite reumatóide, asma, eslcerose múltipla e doença cardìaca em um mamìfero e de tratar, prevenir ou controlar a sìndrome de dor regional complexa

Also Published As

Publication number Publication date
NZ552027A (en) 2009-10-30
EP1791423A1 (en) 2007-06-06
JP2008508354A (ja) 2008-03-21
JP4820819B2 (ja) 2011-11-24
RU2007102720A (ru) 2008-09-10
EP1791423A4 (en) 2009-06-17
ZA200700694B (en) 2007-11-28
WO2006022762A1 (en) 2006-03-02
AU2004322710A1 (en) 2006-03-02
PL1791423T3 (pl) 2013-09-30
ES2422893T3 (es) 2013-09-16
WO2006022762B1 (en) 2006-05-04
AU2004322710B2 (en) 2011-03-31
CN101132693B (zh) 2012-11-07
CN101132693A (zh) 2008-02-27
PT1791423E (pt) 2013-08-02
EP1791423B1 (en) 2013-05-01
RU2366412C2 (ru) 2009-09-10

Similar Documents

Publication Publication Date Title
DK1830838T3 (da) Sammensætninger og fremgangsmåder til behandling af neoplastiske sygdomme
DK1791791T3 (da) Fremgangsmåder og sammensætninger til behandling af vand
DK1765327T3 (da) Forbindelser, sammensætninger og fremgangsmåder
DK1888033T3 (da) Fremgangsmåde og sammensætning til behandling af inflammatoriske sygdomme
DK1948852T3 (da) Hovedelektrode og fremgangsmåde til dannelse af hovedelektroden
IS8204A (is) Tæki og aðferð til að hluta niður
DK1725253T3 (da) Medikamenter og fremgangsmåder til behandling af hovedpine
DK1805312T3 (da) Fremgangsmåder og midler til fremstilling af hyaluronan
DK2101819T3 (da) Fremgangsmåder, sammensætninger og kits til behandling af smerte og pruritis
DK1628530T3 (da) Fremgangsmåder og sammensætninger til forebyggelse og behandling af sepsis
DK1667986T3 (da) Acetonesolvat af dimethoxydocetaxel og fremgangsmåde til fremstilling heraf
DK1644021T3 (da) Fremgangsmåder og sammensætninger til behandlingen af gastrointestinale sygdomme
EP1812031A4 (en) COMPOSITIONS AND METHOD FOR MODIFYING BIOMOLECULES
EP1940423A4 (en) METHODS AND COMPOSITIONS OF TISSUE GENIUS
DK1969391T3 (da) Tyndfilm emitter-absorber indretning og fremgangsmåde
DK2010676T3 (da) Fremgangsmåde og kit til molekylær kromosomal kvantificering
DK2037936T3 (da) Fremgangsmåde til behandling og forebyggelse af sekundær hyperparathyroidisme
DK1667730T3 (da) Sammensætninger og fremgangsmåder til behandling af inflammatorisk lungesygdom
DK3263112T3 (da) Sammensætninger og fremgangsmåder til undertrykkelse af endometriproliferationer
DE602005001520D1 (de) Zeiteinstellungssystem und Zeiteinstellungsverfahren
DK2187967T3 (da) Fremgangsmåde og sammensætninger til behandling af cancere
DK2146742T3 (da) Cellelinjer, sammensætninger omfattende disse til behandling af melanomer, fremgangsmåder til at fremstille sammensætningerne og behandlingsmetoder
DK2110135T3 (da) Farmaceutisk sammensætning til behandling af depression og fremgangsmåde til fremstilling deraf
DK1986508T3 (da) Fremgangsmåder og sammensætninger til behandling af felin hyperthyroidisme
DK1791423T3 (da) Sammensætninger og fremgangsmåder til behandling af hyperproliferative dermatologiske tilstande